See All Slides - tctmd.com

Slides

Presentation TCT 2012

Intravascular Photoacoustics: Progress and Potential for Vulnerable Plaque Imaging

Presenter: Antonius van der Steen

October 22, 2012

Presentation TCT 2012

Statement: Second Generation DES Are Safer Than BMS and Should Be Used in All Patients

Presenter: Marco Valgimigli

October 25, 2012

Presentation TCT 2012

Debate: Transradial Access Should Be the Default Access Site in STEMI Patients!

Presenter: Jennifer Tremmel

October 25, 2012

Presentation TCT 2012

Study Design Issues with RESPECT and the PC Trial

Presenter: Sanjay Kaul

October 26, 2012

Presentation TCT 2012

With These Randomized Data: What's Next for Clinical Practice, Device Development, and Future Research?

Presenter: Brian Whisenant

October 26, 2012

Presentation TCT 2012

How to Write Publishable Papers (with Examples of Dos and Don'ts

Presenter: Anthony DeMaria

October 25, 2012

Presentation TCT 2012

Autologous vs. Allogeneic Cardiac Stem Cells: The Allstar Trial

Presenter: Raj Makkar

October 22, 2012

Presentation TCT 2012

Transcatheter Mitral Valve Devices on the Horizon

Presenter: Jason Rogers

October 24, 2012

Presentation TCT 2012

Managing a Peripheral Coronary Perforation

Presenter: Koen Teeuwen

October 25, 2012

Presentation TCT 2012

TCT-56. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding Events After Percutaneous Coronary Intervention

Presenter: Fabio Mangiacapra

October 23, 2012

Advertisement

Slides

Intravascular Photoacoustics: Progress and Potential for Vulnerable Plaque Imaging

Statement: Second Generation DES Are Safer Than BMS and Should Be Used in All Patients

Debate: Transradial Access Should Be the Default Access Site in STEMI Patients!

Study Design Issues with RESPECT and the PC Trial

With These Randomized Data: What's Next for Clinical Practice, Device Development, and Future Research?

How to Write Publishable Papers (with Examples of Dos and Don'ts

Autologous vs. Allogeneic Cardiac Stem Cells: The Allstar Trial

Transcatheter Mitral Valve Devices on the Horizon

Managing a Peripheral Coronary Perforation

TCT-56. Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding Events After Percutaneous Coronary Intervention

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content